Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02940769 · ClinicalTrials.gov registry record · NA

Neurobiological Effects of Light on MDD

A NA study, sponsored by University of Michigan.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT02940769 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02940769, a NA study, was terminated before completion, sponsored by University of Michigan.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The primary study objective is to observe/measure the circadian pattern of sleep, Cortisol and Melatonin in MDD subjects and Control subjects. We will also assess if controlled exposure to light in MDD subjects (post-partum females, non- post-partum females and males) will change these parameters using light glasses. In addition to the biological outcome measures (sleep, cortisol and melatonin) we will also monitor sleep and depressive symptoms in the research subjects for the duration of the protocol.

Interventions

  • DEVICE light glasses
  • DEVICE sham glasses (placebo)

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2014-09-04
Est. Completion 2017-02-14
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02940769

The ClinicalTrials.gov registry entry for NCT02940769 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which light glasses is the first listed.

NCT02940769 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02940769 about?

NCT02940769 is a clinical study titled "Neurobiological Effects of Light on MDD". The primary study objective is to observe/measure the circadian pattern of sleep, Cortisol and Melatonin in MDD subjects and Control subjects. We will also assess if controlled exposure to light in MDD subjects (post-partum females, non- post-partum females and males) will change these parameters us...

What is the current status of trial NCT02940769?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2014-09-04. Estimated completion is 2017-02-14.

What interventions are being tested in trial NCT02940769?

The interventions under investigation include: light glasses (DEVICE), sham glasses (placebo) (DEVICE).

Who is sponsoring clinical trial NCT02940769?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.